Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
McKesson's (MCK) Latest JV to Boost Cancer Treatment Options
04:31pm, Friday, 24'th Jun 2022 Zacks Investment Research
McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.
Zacks Industry Outlook Highlights Omnicell, Axonics and Outset Medical
09:10am, Friday, 24'th Jun 2022 Zacks Investment Research
Omnicell, Axonics and Outset Medical have been highlighted in this Industry Outlook article.
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
04:16pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.
Change Healthcare (CHNG)-Luma Launch Patient Engagement Suite
04:04pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Change Healthcare's (CHNG) latest launch is expected to significantly improve patients' healthcare journey and create a more streamlined patient experience.
3 Medical Info System Stocks Braving Industry Headwinds
12:58pm, Thursday, 23'rd Jun 2022 Zacks Investment Research
Medical Info Systems stocks like Omnicell, Inc. (OMCL), Axonics, Inc. (AXNX) and Outset Medical, Inc. (OM) are expected to gain despite pandemic-led disruptions.
Should Vanguard S&P SmallCap 600 Growth ETF (VIOG) Be on Your Investing Radar?
10:20am, Thursday, 23'rd Jun 2022 Zacks Investment Research
Style Box ETF report for VIOG
3 Medical Info System Stocks Braving Industry Headwinds
10:03am, Thursday, 23'rd Jun 2022
Medical Info Systems stocks like Omnicell, Inc. (OMCL), Axonics, Inc. (AXNX) and Outset Medical, Inc. (OM) are expected to gain despite pandemic-led disruptions.
Here's Why You Should Hold on to Inogen (INGN) Stock For Now
04:24pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
Veeva Systems (VEEV) Inks Deal to Serve Rare Disease Patients
03:46pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Veeva Development Cloud business.
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?
10:20am, Tuesday, 21'st Jun 2022 Zacks Investment Research
Style Box ETF report for SPSM
Here's Why You Should Hold on to DaVita (DVA) Stock For Now
04:11pm, Monday, 20'th Jun 2022 Zacks Investment Research
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Privia Health (PRVA) Surges 8.1%: Is This an Indication of Further Gains?
11:42am, Monday, 20'th Jun 2022 Zacks Investment Research
Privia Health (PRVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t
Here's Why You Should Hold on to Abiomed (ABMD) Stock For Now
03:33pm, Friday, 17'th Jun 2022 Zacks Investment Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
Here's Why You Should Hold on to Surmodics (SRDX) Stock For Now
02:52pm, Thursday, 16'th Jun 2022 Zacks Investment Research
Investors continue to be optimistic about Surmodics (SRDX) owing to its consistent efforts to boost R&D.
Anthem (ANTM) Unveils Two Brands to Boost Whole Person Health
02:43pm, Thursday, 16'th Jun 2022 Zacks Investment Research
Anthem (ANTM) launches Carelon and Wellpoint brands to streamline its products and services portfolio as well as bring about enhanced health plans for clients and consumers.
